The U.S. Food and Drug Administration approved the first COVID-19 vaccine Monday
The Pfizer-BioNTech COVID-19 Vaccine will now be marketed as Comirnaty (koemir’-na-tee) for the prevention of COVID-19 disease in individuals 16 years of age and older, according to the Centers for Disease Control and Prevention.
The vaccine also continues to be available under emergency use authorization, including for…
